![Karl D. Handelsman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karl D. Handelsman
Fundador en
Codon Capital
.
Perfil
Karl D.
Handelsman is the founder of Codon Innovation LLC, which was founded in 2013.
He is currently working as an Investment Director at Roche Ventures since 2017.
Additionally, he holds director positions at Good Therapeutics, Inc. and Bonum Therapeutics, Inc. Mr. Handelsman has previously worked as a Director of Business Development at Millennium Pharmaceuticals, Inc. from 1996 to 1997.
He also served as an Independent Director at Tetraphase Pharmaceuticals, Inc. in 2013.
From 1999 to 2013, he was a Managing Director at Presidio Partners.
Mr. Handelsman has held director positions at Neos Therapeutics, Inc., Intellikine LLC, Velocity Pharmaceutical Development LLC, Tularik, Inc., and Whitehead Institute for Biomedical Research.
He completed his graduate degree at Harvard University, undergraduate degree at Boston University, and obtained an MBA from Massachusetts Institute of Technology.
Cargos activos de Karl D. Handelsman
| Empresas | Cargo | Inicio |
|---|---|---|
Roche Ventures
 Roche Ventures Investment ManagersFinance Roche Ventures invests in companies located in Switzerland and the United States. The firm focuses on pharmaceuticals, diagnostics and digital health. It participates in early stage capital transactions with an investment size of CHF 3 - 10 million. It acquires minority stakes and also makes follow-on financing. | Inversor de Capital Privado | 01/01/2017 |
Good Therapeutics, Inc.
 Good Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops bio-therapeutics and self-regulating drugs | Director/Miembro de la Junta | - |
Bonum Therapeutics, Inc.
 Bonum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antibody-controlled cytokine based therapeutics designed to enhance the anti-tumor immune response | Director/Miembro de la Junta | - |
Codon Capital
 Codon Capital Investment ManagersFinance Functions as an alternative investment manager | Fundador | 01/01/2013 |
Antiguos cargos conocidos de Karl D. Handelsman.
| Empresas | Cargo | Fin |
|---|---|---|
| TETRAPHASE PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/03/2013 |
Presidio Partners
 Presidio Partners Investment ManagersFinance Presidio Partners invests in companies located in the US. The firm targets companies operating in the fields of information technology, life sciences, and energy technology. They provide financing for early and late stage capital requirements. | Inversor de Capital Privado | 01/01/2013 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/01/1997 |
Velocity Pharmaceutical Development LLC
 Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Develops pharmaceutical drugs | Director/Miembro de la Junta | - |
| NEOS THERAPEUTICS, INC. | Director/Miembro de la Junta | - |
Formación de Karl D. Handelsman.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
66
Relaciones de 1er grado
15
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 15 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Presidio Partners
Presidio Partners Investment ManagersFinance Presidio Partners invests in companies located in the US. The firm targets companies operating in the fields of information technology, life sciences, and energy technology. They provide financing for early and late stage capital requirements. | Finance |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Commercial Services |
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets central nervous system-focused products | Health Technology |
Roche Ventures
Roche Ventures Investment ManagersFinance Roche Ventures invests in companies located in Switzerland and the United States. The firm focuses on pharmaceuticals, diagnostics and digital health. It participates in early stage capital transactions with an investment size of CHF 3 - 10 million. It acquires minority stakes and also makes follow-on financing. | Finance |
Intellikine LLC
 Intellikine LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs for the treatment of cancer | Health Technology |
Velocity Pharmaceutical Development LLC
Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Develops pharmaceutical drugs | Retail Trade |
Good Therapeutics, Inc.
Good Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops bio-therapeutics and self-regulating drugs | Health Technology |
Codon Capital
Codon Capital Investment ManagersFinance Functions as an alternative investment manager | Finance |
Bonum Therapeutics, Inc.
Bonum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antibody-controlled cytokine based therapeutics designed to enhance the anti-tumor immune response | Commercial Services |
- Bolsa de valores
- Insiders
- Karl D. Handelsman
